Fair Value Measurements - Narrative (Details) $ in Millions |
1 Months Ended | ||||||
---|---|---|---|---|---|---|---|
Jul. 31, 2023
USD ($)
item
|
Dec. 31, 2023
USD ($)
|
Jun. 30, 2023
USD ($)
|
Mar. 31, 2023
USD ($)
|
Jul. 01, 2022
USD ($)
|
May 31, 2021
USD ($)
|
Apr. 06, 2021
USD ($)
|
|
Exchange Traded Investment Grade Bond Funds | |||||||
Investments, Total | $ 25.0 | ||||||
Investments, Fair Value Disclosure, Total | 23.7 | ||||||
Asuragen, Inc. | |||||||
Contingent consideration | 2.0 | $ 18.3 | |||||
Maximum contingent consideration | $ 105.0 | ||||||
Namocell Inc | |||||||
Contingent consideration | $ 1.5 | $ 10.6 | |||||
Maximum contingent consideration | $ 25.0 | ||||||
Forward starting swaps | Cash flow hedges | Designated as hedging instruments | |||||||
Derivative, Notional Amount | $ 100.0 | $ 200.0 | |||||
Cross-currency swap | Net investment hedge | Designated as hedging instruments | |||||||
Derivative, Notional Amount | $ 150.0 | ||||||
Number of interim settlement dates | item | 4 | ||||||
Notional amount at maturity | $ 110.0 | ||||||
Decrease in notional amount at each interim date | $ 10.0 |
X | ||||||||||
- Definition Amount of decrease in notional amount of derivatives. No definition available.
|
X | ||||||||||
- Definition Nominal or face amount of derivatives at maturity. No definition available.
|
X | ||||||||||
- Definition Number of interim settlement dates for the derivative instruments. No definition available.
|
X | ||||||||||
- Definition For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of liability recognized arising from contingent consideration in a business combination. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Nominal or face amount used to calculate payment on derivative. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Sum of the carrying amounts as of the balance sheet date of all investments. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|